Johnson & Johnson (NYSE:JNJ)‘s stock had its “buy” rating reaffirmed by equities research analysts at Royal Bank Of Canada in a note issued to investors on Sunday. A number of other brokerages have also recently commented on JNJ. Deutsche Bank AG reiterated a “buy” rating on shares of Johnson & Johnson in a report on […]
